Alaunos Therapeutics, Inc. Share Price & Technical Analysis
TCRT · $2.44 (-6.87%)
Healthcare / Biotechnology
$2.44
-6.87%
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos The…
Price chart
Seasonality
Jun has 2 positive and 2 negative years (last 5 years shown)
-20% return in Jun, 16% avg return in past 3 year Jun month.
-35% return in 2026, -43% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -21% | 19% | -6% | -14% | 8% | -20% | – | – | – | – | – | – | -35% |
| 25 | -11% | -12% | 0% | 79% | 4% | 85% | -44% | -25% | 14% | 13% | 22% | -3% | 122% |
| 24 | 113% | -10% | -13% | -30% | -16% | -38% | -44% | -30% | 23% | -37% | 30% | -32% | -85% |
| 23 | 9% | -24% | 13% | -8% | -12% | 0% | -17% | -68% | -7% | -38% | -12% | 0% | -167% |
| 22 | -1% | -5% | -32% | -18% | -7% | 121% | -6% | 112% | -29% | -34% | -45% | 3% | 60% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Neutral
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$6.72M
P/E ratio
—
52W high
$6.20
52W low
$1.67
Volume
22,587
Beta
-1.13
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is Alaunos Therapeutics, Inc. share price today?
- Alaunos Therapeutics, Inc. (TCRT) last traded around $2.44 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does TCRT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for TCRT. Download the app for real-time alerts.
- How can I analyze Alaunos Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.